Malignant ureteral obstruction: preliminary results of treatment with metallic self-expandable stents
- PMID: 8416559
- DOI: 10.1148/radiology.186.1.8416559
Malignant ureteral obstruction: preliminary results of treatment with metallic self-expandable stents
Abstract
Self-expandable metal stents 7 mm in diameter were percutaneously implanted into 13 ureters in 10 patients with malignant ureteral obstruction not amenable to double-J stent placement. In nine ureters, one stent was placed, and in four ureters, two overlapping stents were placed. Primary reconstitution of ureteral patency was achieved in all ureters. After 1-2 weeks, four ureters showed a urothelial reaction encroaching on the lumen of the ureter, and a double-J stent was placed coaxially. One ureter was occluded by urothelial hyperplasia 4 weeks after stent placement, and a double-J stent was therefore placed. One ureter was occluded 8 months after stent placement by distal tumor overgrowth. The other ureters showed no signs of obstruction during a follow-up of 3-14 (average, 5.8) months. Peristalsis was preserved at both ends of the stent in all ureters. The use of this stent alone or in combination with a double-J stent alleviated upper urinary tract obstruction and avoided external drainage in all patients.
Similar articles
-
Urothelial hyperplasia complicating use of metal stents in malignant ureteral obstruction.Eur Radiol. 1996;6(5):675-81. doi: 10.1007/BF00187672. Eur Radiol. 1996. PMID: 8934134
-
Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: comparison with double J stent insertion.Cardiovasc Intervent Radiol. 2014 Apr;37(2):463-70. doi: 10.1007/s00270-013-0675-2. Epub 2013 Aug 8. Cardiovasc Intervent Radiol. 2014. PMID: 23925919
-
Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.J Urol. 2009 Dec;182(6):2613-7. doi: 10.1016/j.juro.2009.08.040. J Urol. 2009. PMID: 19836807 Review.
-
Metal stents: a new treatment of malignant ureteral obstruction.J Urol. 1997 Jul;158(1):54-8. doi: 10.1097/00005392-199707000-00015. J Urol. 1997. PMID: 9186322 Clinical Trial.
-
Ureteral metal stents: a tale or a tool?J Endourol. 2005 Oct;19(8):934-9. doi: 10.1089/end.2005.19.934. J Endourol. 2005. PMID: 16253054 Review.
Cited by
-
Palliative treatment of malignant esophageal obstruction with metallic Wallstent.Dig Dis Sci. 1994 Dec;39(12):2685-8. doi: 10.1007/BF02087710. Dig Dis Sci. 1994. PMID: 7527754 No abstract available.
-
Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.Eur Radiol. 2006 Sep;16(9):2016-30. doi: 10.1007/s00330-005-0136-7. Epub 2006 Mar 18. Eur Radiol. 2006. PMID: 16547709 Review.
-
REVIEW ON COMPLICATIONS AND ADVERSE EFFECTS OF METALLIC URINARY STENTS.Acta Clin Croat. 2023 Jul;62(Suppl2):114-122. doi: 10.20471/acc.2023.62.s2.16. Acta Clin Croat. 2023. PMID: 38966022 Free PMC article. Review.
-
Urothelial hyperplasia complicating use of metal stents in malignant ureteral obstruction.Eur Radiol. 1996;6(5):675-81. doi: 10.1007/BF00187672. Eur Radiol. 1996. PMID: 8934134
-
Efficacy and Safety of Self-Expandable Covered Metallic Stents for Benign and Malignant Ureteral Obstructions: A Long-Term Retrospective Study.Medicina (Kaunas). 2025 Feb 17;61(2):351. doi: 10.3390/medicina61020351. Medicina (Kaunas). 2025. PMID: 40005467 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources